Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2014	Apr. 30, 2014 Class A	Apr. 30, 2014 Class B	Apr. 30, 2014 Class C	Apr. 30, 2014 Class D
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1
Trading Symbol	UHS
Entity Registrant Name	UNIVERSAL HEALTH SERVICES INC
Entity Central Index Key	0000352915
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		6,595,708	91,495,048	664,000	29,793

Condensed Consolidated Statements of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net revenues before provision for doubtful accounts	$ 2,128,350	$ 2,078,348
Less: Provision for doubtful accounts	208,184	246,716
Net revenues	1,920,166	1,831,632
Operating charges:
Salaries, wages and benefits	935,365	902,296
Other operating expenses	381,760	381,007
Supplies expense	215,798	204,642
Depreciation and amortization	93,359	79,812
Lease and rental expense	23,338	24,665
Electronic health records incentive income	(430)	(4,712)
Operating Expenses, Total	1,649,190	1,587,710
Income from operations	270,976	243,922
Interest expense, net	35,193	39,938
Income before income taxes	235,783	203,984
Provision for income taxes	83,931	74,049
Net income	151,852	129,935
Less: Income attributable to noncontrolling interests	13,774	10,151
Net income attributable to UHS	$ 138,078	$ 119,784
Basic earnings per share attributable to UHS	$ 1.40	$ 1.23
Diluted earnings per share attributable to UHS	$ 1.38	$ 1.21
Weighted average number of common shares - basic	98,572	97,711
Add: Other share equivalents	1,585	860
Weighted average number of common shares and equivalents - diluted	100,157	98,571

Condensed Consolidated Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net income	$ 151,852	$ 129,935
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges	3,745	4,535
Amortization of terminated hedge	(84)	(84)
Other comprehensive income before tax	3,661	4,451
Income tax expense related to items of other comprehensive income	1,354	1,678
Total other comprehensive income, net of tax	2,307	2,773
Comprehensive income	154,159	132,708
Less: Comprehensive income attributable to noncontrolling interests	13,774	10,151
Comprehensive income attributable to UHS	$ 140,385	$ 122,557

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 16,261	$ 17,238	$ 17,395	$ 23,471
Accounts receivable, net	1,212,594	1,116,961
Supplies	102,276	101,781
Deferred income taxes	114,297	119,903
Other current assets	97,685	76,446
Total current assets	1,543,113	1,432,329
Property and equipment	5,789,393	5,691,902
Less: accumulated depreciation	(2,321,221)	(2,249,733)
Property, plant and equipment, net, Total	3,468,172	3,442,169
Other assets:
Goodwill	3,053,666	3,049,016
Deferred charges	53,521	57,881
Other	312,913	330,328
Total assets	8,431,385	8,311,723	8,316,508
Current liabilities:
Current maturities of long-term debt	103,641	99,312
Accounts payable and accrued liabilities	954,902	953,449
Federal and state taxes	51,905	7,127
Total current liabilities	1,110,448	1,059,888
Other noncurrent liabilities	282,173	284,589
Long-term debt	3,109,158	3,209,762
Deferred income taxes	257,344	239,148
Redeemable noncontrolling interests	228,107	218,107
Equity:
UHS common stockholders' equity	3,392,119	3,249,979
Noncontrolling interest	52,036	50,250
Total equity	3,444,155	3,300,229
Liabilities and Equity, Total	$ 8,431,385	$ 8,311,723

Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash Flows from Operating Activities:
Net income	$ 151,852	$ 129,935
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation & amortization	93,359	79,923
Stock-based compensation expense	7,152	7,111
Gains on sales of assets and businesses, net of losses	(10,134)	(2,092)
Changes in assets & liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	(95,633)	(81,859)
Accrued interest	11,063	11,497
Accrued and deferred income taxes	65,321	59,624
Other working capital accounts	(34,999)	(39,785)
Other assets and deferred charges	9,982	6,662
Other	(3,833)	1,604
Accrued insurance expense, net of commercial premiums paid	21,302	22,962
Payments made in settlement of self-insurance claims	(20,793)	(17,085)
Net cash provided by operating activities	194,639	178,497
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(92,387)	(95,919)
Proceeds received from sale of assets and businesses	11,450	6,657
Acquisition of property and businesses	(3,301)	0
Costs incurred for purchase and implementation of electronic health records application	(6,504)	(16,412)
Net cash provided by (used in) investing activities	(90,742)	(105,674)
Cash Flows from Financing Activities:
Reduction of long-term debt	(109,054)	(69,926)
Additional borrowings	11,900	9,500
Repurchase of common shares	(13,993)	(14,027)
Dividends paid	(4,933)	(4,870)
Issuance of common stock	1,445	1,232
Excess income tax benefits related to stock-based compensation	11,750	9,266
Profit distributions to noncontrolling interests	(1,989)	(10,074)
Net cash (used in) provided by financing activities	(104,874)	(78,899)
Decrease in cash and cash equivalents	(977)	(6,076)
Cash and cash equivalents, beginning of period	17,238	23,471
Cash and cash equivalents, end of period	16,261	17,395
Supplemental Disclosures of Cash Flow Information:
Interest paid	18,893	22,982
Income taxes paid, net of refunds	$ 6,764	$ 4,908

General

3 Months Ended

Mar. 31, 2014

General

(1) General

This Quarterly Report on Form 10-Q is for the quarterly period ended March 31, 2014. In this Quarterly Report, “we,” “us,” “our” “UHS” and the “Company” refer to Universal Health Services, Inc. and its subsidiaries.

The condensed consolidated financial statements include the accounts of our majority-owned subsidiaries and partnerships and limited liability companies controlled by us, or our subsidiaries, as managing general partner or managing member. The condensed consolidated financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all adjustments (consisting only of normal recurring adjustments) which, in our opinion, are necessary to fairly state results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe that the accompanying disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements, significant accounting policies and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2013.

Relationship with Universal Health Realty Income Trust and Related Party Transactions

3 Months Ended

Mar. 31, 2014

Relationship with Universal Health Realty Income Trust and Related Party Transactions

(2) Relationship with Universal Health Realty Income Trust and Related Party Transactions

Relationship with Universal Health Realty Income Trust:

At March 31, 2014, we held approximately 6.1% of the outstanding shares of Universal Health Realty Income Trust (the “Trust”). We serve as Advisor to the Trust under an annually renewable advisory agreement pursuant to the terms of which we conduct the Trust’s day-to-day affairs, provide administrative services and present investment opportunities. In addition, certain of our officers and directors are also officers and/or directors of the Trust. Management believes that it has the ability to exercise significant influence over the Trust, therefore we account for our investment in the Trust using the equity method of accounting. We earned an advisory fee from the Trust, which is included in net revenues in the accompanying condensed consolidated statements of income, of approximately $600,000 during each of the three-month periods ended March 31, 2014 and 2013. Our pre-tax share of income from the Trust was $300,000 during each of the three-month periods ended March 31, 2014 and 2013. The carrying value of this investment was approximately $8 million at each of March 31, 2014 and December 31, 2013, and is included in other assets in the accompanying condensed consolidated balance sheets. The market value of this investment, based on the closing price of the Trust’s stock on the respective dates, was approximately $33 million at March 31, 2014 and $32 million at December 31, 2013.

Total rent expense under the operating leases on the hospital facilities with the Trust was approximately $4 million during each of the three-month periods ended March 31, 2014 and 2013. In addition, certain of our subsidiaries are tenants in several medical office buildings owned by limited liability companies in which the Trust holds either 100% ownership interests or non-controlling majority ownership interests.

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Other Related Party Transactions:

In December, 2010, our Board of Directors approved the Company’s entering into supplemental life insurance plans and agreements on the lives of our chief executive officer and his wife. As a result of these agreements, based on actuarial tables and other assumptions, during the life expectancies of the insureds, we would pay approximately $25 million in premiums and certain trusts, owned by our chief executive officer, would pay approximately $8 million in premiums. Based on the projected premiums mentioned above, and assuming the policies remain in effect until the death of the insureds, we will be entitled to receive death benefit proceeds of no less than $33 million representing the $25 million of aggregate premiums paid by us as well as the $8 million of aggregate premiums paid by the trusts. These agreements did not have a material effect on our consolidated financial statements or results of operations during 2013 or the first three months of 2014.

A member of our Board of Directors and member of the Executive Committee is Of Counsel to the law firm used by us as our principal outside counsel. This Board member is also the trustee of certain trusts for the benefit of our Chief Executive Officer (“CEO”) and his family. This law firm also provides personal legal services to our CEO.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References+ Details

Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

3 Months Ended

Mar. 31, 2014

Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

(3) Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

Other noncurrent liabilities include the long-term portion of our professional and general liability, workers’ compensation reserves, pension liability, and interest rate swaps.

Outside owners hold noncontrolling, minority ownership interests of: (i) approximately 28% in our five acute care facilities located in Las Vegas, Nevada; (ii) 20% in an acute care facility located in Washington, D.C.; (iii) approximately 11% in an acute care facility located in Laredo, Texas, and; (iv) 20% in a behavioral health care facility located in Philadelphia, Pennsylvania. The redeemable noncontrolling interest balances of $228 million and $218 million as of March 31, 2014 and December 31, 2013, respectively, and the noncontrolling interest balances of $52 million and $50 million as of March 31, 2014 and December 31, 2013, respectively, consist primarily of the third-party ownership interests in these hospitals.

In connection with the five acute care facilities located in Las Vegas, Nevada, the minority ownership interests of which are reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owners have certain “put rights”, that are currently exercisable, that if exercised, require us to purchase the minority member’s interests at fair market value. The put rights are exercisable upon the occurrence of: (i) certain specified financial conditions falling below established thresholds; (ii) breach of the management contract by the managing member (a subsidiary of ours), or; (iii) if the minority member’s ownership percentage is reduced to less than certain thresholds. In connection with the behavioral health care facility located in Philadelphia, Pennsylvania, the minority ownership interest of which is also reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owner has a “put option” to put its entire ownership interest to us at any time. If exercised, the put option requires us to purchase the minority member’s interest at fair market value. As of March 31, 2014, we believe the fair market value of the minority ownership interests in these facilities, pursuant to the terms of the put options, approximates the book value of the redeemable noncontrolling interests.

Long-term debt and cash flow hedges

3 Months Ended

Mar. 31, 2014

Long-term debt and cash flow hedges

(4) Long-term debt and cash flow hedges

Debt:

In May, 2013, we entered into a third amendment (the “Third Amendment”) to the credit agreement, dated as of November 15, 2010 (as amended from time to time, the “Credit Agreement”), which became effective that day, among UHS, the several banks and other financial institutions from time to time parties thereto, JPMorgan Chase Bank, N.A., as administrative agent and the other agents party thereto. The Third Amendment provides for a reduction in the interest rates payable in connection with certain borrowings under the Credit Agreement. Upon the effectiveness of the Third Amendment, UHS replaced its existing $745.9 million senior secured Tranche B term loan with a new senior secured Tranche B-1 term loan in the same amount on substantially the same terms as the Tranche B term loan, other than lower interest rates. Borrowings under the Tranche B-1 term loan, which totaled $550 million as of March 31, 2014, bear interest at a rate per annum equal to, at our election, one, two, three or six month LIBOR, plus an applicable margin of 2.25% or ABR plus an applicable margin of 1.25%. The minimum LIBOR and ABR rates for the Tranche B term loan of 1.0% and 2.0%, respectively, were eliminated.

In September, 2012, we entered into a second amendment (“Second Amendment”) to our Credit Agreement which provided for: (i) a new Term Loan-A facility (“Term Loan A2”), which had $866 million of borrowings outstanding at March 31, 2014, at the same interest rates as our existing Term Loan A and a final maturity date of August 15, 2016; (ii) the extension of the maturity date on a substantial portion of our $800 million revolving credit facility commitment with $777 million of the commitment extended to mature on August 15, 2016 and the remaining $23 million commitment scheduled to mature on November 15, 2015 (there were $7 million of borrowings outstanding pursuant to our revolving credit facility as of March 31, 2014), and; (iii) the extension of the maturity date on a substantial portion of our Term Loan-A borrowings which, based upon the outstanding Term Loan-A borrowings as of March 31, 2014, $884 million is scheduled to mature on August 15, 2016 and the remaining $42 million is scheduled to mature on November 15, 2015. The Second Amendment also provides for increased flexibility for refinancing and certain other modifications but substantially all other terms of the Credit Agreement remain unchanged.

The Credit Agreement, as amended, is a senior secured facility which, as of March 31, 2014, provided for an aggregate commitment amount of $3.14 billion, comprised of an $800 million revolving credit facility, a $926 million Term Loan-A facility, a $550 million Term Loan-B facility and a $866 million Term Loan-A2 facility. The revolving credit facility includes a $125 million sub-limit for letters of credit. The Credit Agreement is secured by substantially all of the assets of the Company and our material subsidiaries and guaranteed by our material subsidiaries.

Borrowings under the Credit Agreement bear interest at either (1) the ABR rate which is defined as the rate per annum equal to, at our election: the greatest of (a) the lender’s prime rate, (b) the weighted average of the federal funds rate, plus 0.5% and (c) one month LIBOR rate plus 1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.50% to 1.25% for revolving credit, Term Loan-A and Term Loan-A2 borrowings and 1.25% for Term Loan B borrowings or (2) the one, two, three or six month LIBOR rate (at our election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.50% to 2.25% for revolving credit, Term Loan-A and Term Loan-A2 borrowings and 2.25% for Term Loan-B borrowings. The current applicable margins are 0.50% for ABR-based loans, 1.50% for LIBOR-based loans under the revolving credit, Term Loan-A and Term Loan-A2 facilities and 2.25% under the Term Loan-B facility.

As of March 31, 2014, we had $7 million of borrowings outstanding pursuant to the terms of our $800 million revolving credit facility and we had $743 million of available borrowing capacity, net of $30 million of outstanding borrowings pursuant to a short-term, on-demand credit facility and $20 million of outstanding letters of credit.

We made scheduled principal payments of $18 million on the Term Loan-A and Term Loan A2 facilities during each of the three-month periods ended March 31, 2014 and 2013. Quarterly installment payments (“Installment Payments”) are due on the Term Loan-A and Term Loan-A2 facilities which approximate $54 million during the remainder of 2014, $77 million in 2015 and $46 million in 2016. The Installment Payments due as of March 31, 2015 on the Term Loan-A and Term Loan-A2 facilities are classified as current maturities of long-term debt on our Consolidated Balance Sheet as of March 31, 2014. No Installment Payments are due on the Term Loan-B facility, although we may decide to make optional repayments from time-to-time.

In October, 2013 our $275 million accounts receivable securitization program (“Securitization”) with a group of conduit lenders and liquidity banks was amended to extend the maturity date to October 25, 2016 and reduce the interest rate spread and commitment fee. Substantially all of the patient-related accounts receivable of our acute care hospitals (“Receivables”) serve as collateral for the outstanding borrowings. We have accounted for this Securitization as borrowings. We maintain effective control over the Receivables since, pursuant to the terms of the Securitization, the Receivables are sold from certain of our subsidiaries to special purpose entities that are wholly-owned by us. The Receivables, however, are owned by the special purpose entities, can be used only to satisfy the debts of the wholly-owned special purpose entities, and thus are not available to us except through our ownership interest in the special purpose entities. The wholly-owned special purpose entities use the Receivables to collateralize the loans obtained from the group of third-party conduit lenders and liquidity banks. The group of third-party conduit lenders and liquidity banks do not have recourse to us beyond the assets of the wholly-owned special purpose entities that securitize the loans. At March 31, 2014, we had $160 million of outstanding borrowings and $115 million of additional capacity pursuant to the terms of our accounts receivable securitization program.

Our $250 million, 7.00% senior unsecured notes (the “Unsecured Notes”) are scheduled to mature on October 1, 2018. The Unsecured Notes were issued on September 29, 2010 and registered in April, 2011. Interest on the Unsecured Note is payable semiannually in arrears on April 1st and October 1st of each year. The Unsecured Notes can be redeemed in whole at anytime subject to a make-whole call at treasury rate plus 50 basis points prior to October 1, 2014. They are also redeemable in whole or in part at a price of: (i) 103.5% on or after October 1, 2014; (ii) 101.75% on or after October 1, 2015, and; (iii) 100% on or after October 1, 2016. These Unsecured Notes are guaranteed by a group of subsidiaries (each of which is a 100% directly or indirectly owned subsidiary of Universal Health Services, Inc.) which fully and unconditionally guarantee the Unsecured Notes on a joint and several basis, subject to certain customary automatic release provisions.

On June 30, 2006, we issued $250 million of senior notes which have a 7.125% coupon rate and mature on June 30, 2016 (the “7.125% Notes”). Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year. In June, 2008, we issued an additional $150 million of 7.125% Notes which formed a single series with the original 7.125% Notes issued in June, 2006. Other than their date of issuance and initial price to the public, the terms of the 7.125% Notes issued in June, 2008 are identical to and trade interchangeably with, the 7.125% Notes which were originally issued in June, 2006.

In connection with the entering into of the Credit Agreement on November 15, 2010, and in accordance with the Indenture dated January 20, 2000 governing the rights of our existing notes, we entered into a supplemental indenture pursuant to which our 7.125% Notes (due in 2016) were equally and ratably secured with the lenders under the Credit Agreement with respect to the collateral for so long as the lenders under the Credit Agreement are so secured.

Our Credit Agreement includes a material adverse change clause that must be represented at each draw. The Credit Agreement contains covenants that include a limitation on sales of assets, mergers, change of ownership, liens and indebtedness, transactions with affiliates and dividends; and requires compliance with financial covenants including maximum leverage and minimum interest coverage ratios. We are in compliance with all required covenants as of March 31, 2014.

As of March 31, 2014, the carrying value of our debt was $3.2 billion and the fair-value of our debt was $3.3 billion. The fair value of our debt was computed based upon quotes received from financial institutions and we consider these to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with debt instruments.

Cash Flow Hedges:

We manage our ratio of fixed and floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts. We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income (“AOCI”) within shareholders’ equity. Amounts are reclassified from AOCI to the income statement in the period or periods the hedged transaction affects earnings. We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

For hedge transactions that do not qualify for the short-cut method, at the hedge’s inception and on a regular basis thereafter, a formal assessment is performed to determine whether changes in the fair values or cash flows of the derivative instruments have been highly effective in offsetting changes in cash flows of the hedged items and whether they are expected to be highly effective in the future.

The fair value of interest rate swap agreements approximates the amount at which they could be settled, based on estimates obtained from the counterparties. We assess the effectiveness of our hedge instruments on a quarterly basis. We performed periodic assessments of the cash flow hedge instruments during 2013 and the first three months of 2014 and determined the hedges to be highly effective. We also determined that any portion of the hedges deemed to be ineffective was de minimis and therefore there was no material effect on our consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose us to credit risk in the event of nonperformance. However, at March 31, 2014, each swap agreement entered into by us was in a net liability position which would require us to make the net settlement payments to the counterparties. We do not anticipate nonperformance by our counterparties. We do not hold or issue derivative financial instruments for trading purposes.

We entered into six forward starting interest rate swaps in the first quarter of 2011 whereby we pay a fixed rate on a total notional amount of $425 million and receive three-month LIBOR. Three of these swaps with a total notional amount of $225 million became effective in March, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 1.91%. The three remaining interest rate swaps with total notional amounts of $100 million, $25 million and $75 million became effective in December, 2011 and have/had fixed rates of 2.50%, 1.96% and 1.32%, and maturity dates in December, 2014, December, 2013 and December, 2012, respectively.

During the fourth quarter of 2010, we entered into four forward starting interest rate swaps whereby we pay a fixed rate on a total notional amount of $600 million and receive three-month LIBOR. Each of the four swaps became effective in December, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 2.38%.

We measure our interest rate swaps at fair value on a recurring basis. The fair value of our interest rate swaps is based primarily on quotes from banks. We consider those inputs to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with derivative instruments and hedging activities. The fair value of our interest rate swaps was an aggregate gross and net liability of $20 million at March 31, 2014, of which $18 million is included in accounts payable and accrued liabilities and $2 million is included in other noncurrent liabilities on the accompanying balance sheet. The fair value of our interest rate swaps was an aggregate gross and net liability of $24 million at December 31, 2013, of which $19 million is included in accounts payable and accrued liabilities and $5 million is included in other noncurrent liabilities on the accompanying balance sheet.

Commitments and Contingencies

3 Months Ended

Mar. 31, 2014

Commitments and Contingencies

(5) Commitments and Contingencies

Professional and General Liability, Workers’ Compensation Liability and Property Insurance

Professional and General Liability and Workers Compensation Liability:

Effective November, 2010, excluding our subsidiaries acquired as a result of our acquisition of Psychiatric Solutions, Inc. (“PSI”) in November, 2010, our subsidiaries are self-insured for professional and general liability exposure up to $10 million and $3 million per occurrence, respectively. Since our acquisition of PSI in November, 2010, the former PSI subsidiaries are self-insured for professional and general liability exposure up to $3 million per occurrence. Our subsidiaries (including the former PSI subsidiaries) were provided with several excess policies through commercial insurance carriers which provide for coverage in excess of the applicable per occurrence self-insured retention (either $3 million or $10 million) up to $250 million per occurrence and in the aggregate. We remain liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate. The 9 behavioral health facilities acquired from Ascend Health Corporation in October, 2012 have general and professional liability policies through commercial insurance carriers which provide for up to $20 million of aggregate coverage, subject to a $25,000 per occurrence deductible. These facilities, like our other facilities, are also provided excess coverage through commercial insurance carriers for coverage in excess of the underlying commercial policy limitations up to $250 million per occurrence and in the aggregate.

Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimates of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Given our significant self-insured exposure for professional and general liability claims, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations.

As of March 31, 2014, the total accrual for our professional and general liability claims was $206 million, of which $44 million is included in current liabilities. As of December 31, 2013, the total accrual for our professional and general liability claims was $206 million, of which $44 million is included in current liabilities.

As of March 31, 2014, the total accrual for our workers’ compensation liability claims was $65 million, of which $34 million is included in current liabilities. As of December 31, 2013, the total accrual for our workers’ compensation liability claims was $64 million, of which $34 million is included in current liabilities

Property Insurance:

We have commercial property insurance policies covering catastrophic losses, including windstorm damage, up to a $1 billion policy limit per occurrence, subject to a $250,000 deductible for the majority of our properties (the properties acquired from PSI are subject to a $50,000 deductible). Losses resulting from named windstorms are subject to deductibles between 3% and 5% of the declared total insurable value of the property. In addition, we have commercial property insurance policies covering catastrophic losses resulting from earthquake and flood damage, each subject to aggregated loss limits (as opposed to per occurrence losses). Our earthquake limit is $250 million, subject to a deductible of $250,000, except for facilities located within documented fault zones. Earthquake losses that affect facilities located in fault zones within the United States are subject to a $100 million limit and will have applied deductibles ranging from 1% to 5% of the declared total insurable value of the property. The earthquake limit in Puerto Rico is $25 million, subject to a $25,000 deductible. Non-critical flood losses have either a $250,000 or $500,000 deductible, based upon the location of the facility. Since certain of our facilities have been designated by our insurer as flood prone, we have elected to purchase policies from The National Flood Insurance Program to cover a substantial portion of the applicable deductible.

Other

Our accounts receivable as of March 31, 2014 and December 31, 2013 include amounts due from Illinois of approximately $39 million and $49 million, respectively. Collection of the outstanding receivables continues to be delayed due to state budgetary and funding pressures. Approximately $14 million as of March 31, 2014 and $28 million as of December 31, 2013, of the receivables due from Illinois were outstanding in excess of 60 days, as of each respective date. In addition, our accounts receivable as of March 31, 2014 and December 31, 2013 includes approximately $40 million and $46 million due from Texas in connection with Medicaid supplemental payment programs (which we expect to collect during 2014). Although the accounts receivable due from Illinois and Texas could remain outstanding for the foreseeable future, since we expect to eventually collect all amounts due to us, no related reserves have been established in our consolidated financial statements. However, we can provide no assurance that we will eventually collect all amounts due to us from Illinois and/or Texas. Failure to ultimately collect all outstanding amounts due from these states would have an adverse impact on our future consolidated results of operations and cash flows.

As of March 31, 2014 we were party to certain off balance sheet arrangements consisting of standby letters of credit and surety bonds which totaled $90 million consisting of: (i) $73 million related to our self-insurance programs, and; (ii) $17 million of other debt and public utility guarantees.

Legal Proceedings

We are subject to claims and suits in the ordinary course of business, including those arising from care and treatment afforded by our hospitals and are party to litigation, as outlined below.

Office of Inspector General (“OIG”) and Other Government Investigations

In September, 2010, we, along with many other companies in the healthcare industry, received a letter from the United States Department of Justice (“DOJ”) advising of a False Claim Act investigation being conducted in connection with the implantation of implantable cardioverter defibrillators (“ICDs”) from 2003 to 2010 at several of our acute care facilities. The DOJ alleges that ICDs were implanted and billed by our facilities in contravention of a National Coverage Determination regarding these devices. We have established a reserve in connection with this matter which did not have a material impact on our consolidated financial statements.

In February, 2013, the OIG served a subpoena requesting various documents from January, 2008 to the date of the subpoena directed at Universal Health Services, Inc. (“UHS”) concerning it and UHS of Delaware, Inc., and several UHS owned behavioral health facilities including: Keys of Carolina, Old Vineyard Behavioral Health, The Meadows Psychiatric Center, Streamwood Behavioral Health, Hartgrove Hospital, Rock River Academy and Residential Treatment Center, Roxbury Treatment Center, Harbor Point Behavioral Health Center, f/k/a, The Pines Residential Treatment Center, including the Crawford, Brighton and Kempsville campuses, Wekiva Springs Center and River Point Behavioral Health. Prior to receiving this subpoena: (i) the Keys of Carolina and Old Vineyard received notification during the second half of 2012 from the United States Department of Justice of its intent to proceed with an investigation following requests for documents for the period of January, 2007 to the date of the subpoenas from the North Carolina state Attorney General’s Office; (ii) Harbor Point Behavioral Health Center received a subpoena in December, 2012 from the Attorney General of the Commonwealth of Virginia requesting various documents from July, 2006 to the date of the subpoena, and; (iii) The Meadows Psychiatric Center received a subpoena from the OIG in February, 2013 requesting certain documents from 2008 to the date of the subpoena. Unrelated to these matters, the Keys of Carolina was closed and the real property was sold in January, 2013.

In April, 2013, the OIG served facility specific subpoenas on Wekiva Springs Center and River Point Behavioral Health requesting various documents from January, 2005 to the date of the subpoenas. In June, 2013, the OIG served a subpoena on Coastal Harbor Health System in Savannah, Georgia requesting documents from January, 2009 to the date of the subpoena. In July, 2013, another subpoena was issued to Wekiva Springs Center and River Point Behavioral Health requesting additional records. In October, 2013, we were advised by the DOJ’s Criminal Frauds Section that they received a referral from the DOJ Civil Division and opened an investigation of River Point Behavioral Health and Wekiva Springs Center.

In February, 2014, we were notified that the investigation conducted by the Criminal Frauds Section had been expanded to include the National Deaf Academy. In March, 2014, a Civil Investigative Demand (“CID”) was served on the National Deaf Academy requesting documents and information from the facility from January 1, 2008 through the date of the CID. We have been advised by the government that the National Deaf Academy has been added to the facilities which are the subject of the coordinated investigation referenced above. Also in March, 2014, CIDs were served on Hartgrove Hospital, Rock River Academy and Streamwood Behavioral Health requesting documents and information from those facilities from January 2008 through the date of the CID. We were recently advised that a qui tam action had been filed against Roxbury Treatment Center but the government declined to intervene and the case was dismissed.

In April, 2014, the Centers for Medicare and Medicaid Services (“CMS”) instituted a Medicare payment suspension at River Point Behavioral Health in accordance with federal regulations which implemented provisions of the Affordable Care Act regarding suspension of payments during certain investigations. The Florida Agency for Health Care Administration subsequently issued a Medicaid payment suspension for the facility. River Point Behavioral Health submitted a rebuttal statement disputing the basis of the suspension and requesting revocation of the suspension. In response, CMS has continued the payment suspension. River Point Behavioral Health continues to provide additional information to CMS in an effort to obtain relief from the payment suspension. We cannot predict if and/or when the facility’s suspended payments will resume. However, if continued for a significant period of time, the payment suspension will likely have a material adverse effect on River Point Behavioral Health’s future results of operations and financial condition. The operating results of River Point Behavioral Health did not have a material impact on our consolidated results of operations for the three-month period ended March 31, 2014 or the year ended December 31, 2013.

At present, we are uncertain as to the specific focus, scope or extent of the investigations, liability of the facilities and/or potential financial exposure, if any, in connection with these matters.

Matters Relating to PSI:

The following matters pertain to PSI or former PSI facilities (owned by subsidiaries of Psychiatric Solutions, Inc.) which were in existence prior to the acquisition of PSI and for which we have assumed the defense as a result of our acquisition which was completed in November, 2010:

Garden City Employees’ Retirement System v. PSI:

This is a purported shareholder class action lawsuit filed in the United States District Court for the Middle District of Tennessee against PSI and the former directors in 2009 alleging violations of federal securities laws. We intend to defend the case vigorously. Should we be deemed liable in this matter, we believe we would be entitled to commercial insurance recoveries for amounts paid by us, subject to certain limitations and deductibles. Included in our consolidated balance sheets as of March 31, 2014 and December 31, 2013, is an estimated reserve (current liability) and corresponding commercial insurance recovery (current asset) which did not have a material impact on our financial statements. Although we believe the commercial insurance recoveries are adequate to satisfy potential liability and related legal fees in connection with this matter, we can provide no assurance that the ultimate liability will not exceed the commercial insurance recoveries which would make us liable for the excess.

Department of Justice Investigation of Friends Hospital:

In October, 2010, Friends Hospital in Philadelphia, Pennsylvania, received a subpoena from the DOJ requesting certain documents from the facility. The requested documents have been collected and provided to the DOJ for review and examination. Another subpoena was issued to the facility in July 2011 requesting additional documents, which have been collected and delivered to the DOJ. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Department of Justice Investigation of Riveredge Hospital:

In 2008, Riveredge Hospital in Chicago, Illinois received a subpoena from the DOJ requesting certain information from the facility. Additional requests for documents were also received from the DOJ in 2009 and 2010. The requested documents have been provided to the DOJ. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

General:

The healthcare industry is subject to numerous laws and regulations which include, among other things, matters such as government healthcare participation requirements, various licensure, certifications, and accreditations, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Government action has increased with respect to investigations and/or allegations concerning possible violations of fraud and abuse and false claims statutes and/or regulations by healthcare providers. Currently, and from time to time, some of our facilities are subjected to inquiries and/or actions and receive notices of potential non-compliance of laws and regulations from various federal and state agencies. Providers that are found to have violated these laws and regulations may be excluded from participating in government healthcare programs, subjected to potential licensure, certification, and/or accreditation revocation, subjected to payment suspension, subjected to fines or penalties or required to repay amounts received from the government for previously billed patient services. We monitor all aspects of our business and have developed a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. Because the law in this area is complex and constantly evolving, governmental investigation or litigation may result in interpretations that are inconsistent with industry practices, including ours. Although we believe our policies, procedures and practices comply with governmental regulations, there is no assurance that we will not be faced with sanctions, fines or penalties in connection with such inquiries or actions, including with respect to the investigations and other matters discussed herein. Even if we were to ultimately prevail, such inquiries and/or actions could have a material adverse effect on us.

The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. We record accruals for such contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because the inherently unpredictable nature of legal proceedings may be exacerbated by various factors, including, but not limited to: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties, or; (vii) there is a wide range of potential outcomes. It is possible that the outcome of these matters could have a material adverse impact on our future results of operations, financial position, cash flows and, potentially, our reputation.

In addition, various suits and claims arising against us in the ordinary course of business are pending. In the opinion of management, the outcome of such claims and litigation will not materially affect our consolidated financial position or results of operations.

- Definition

The entire disclosure for commitments and contingencies.

+ References+ Details

Segment Reporting

3 Months Ended

Mar. 31, 2014

Segment Reporting

(6) Segment Reporting

Our reportable operating segments consist of acute care hospital services and behavioral health care services. The “Other” segment column below includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for our other operating entities including outpatient surgery and radiation centers. The chief operating decision making group for our acute care hospital services and behavioral health care services is comprised of the Chief Executive Officer, the President and the Presidents of each operating segment. The Presidents of each operating segment also manage the profitability of each respective segment’s various facilities. The operating segments are managed separately because each operating segment represents a business unit that offers different types of healthcare services or operates in different healthcare environments. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2013.


	Three months ended March 31, 2014
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	3,876,364		$	1,608,899			—		$	5,485,263
Gross outpatient revenues	$	1,957,491		$	184,115		$	8,514		$	2,150,120
Total net revenues	$	971,391		$	945,457		$	3,318		$	1,920,166
Income/(loss) before allocation of corporate overhead and income taxes	$	111,650		$	221,148		($	97,015	)	$	235,783
Allocation of corporate overhead	($	44,697	)	($	26,169	)	$	70,866			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	66,953		$	194,979		($	26,149	)	$	235,783
Total assets as of 3/31/14	$	3,200,203		$	5,004,478		$	226,704		$	8,431,385


	Three months ended March 31, 2013
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	3,507,270		$	1,576,148			—		$	5,083,418
Gross outpatient revenues	$	1,651,575		$	185,802		$	10,848		$	1,848,225
Total net revenues	$	908,734		$	909,544		$	13,354		$	1,831,632
Income/(loss) before allocation of corporate overhead and income taxes	$	80,629		$	220,775		($	97,420	)	$	203,984
Allocation of corporate overhead	($	46,112	)	($	22,367	)	$	68,479			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	34,517		$	198,408		($	28,941	)	$	203,984
Total assets as of 3/31/13	$	3,077,881		$	4,963,760		$	274,867		$	8,316,508

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

+ Details

Earnings Per Share Data ("EPS") and Stock Based Compensation

3 Months Ended

Mar. 31, 2014

Earnings Per Share Data ("EPS") and Stock Based Compensation

(7) Earnings Per Share Data (“EPS”) and Stock Based Compensation

Basic earnings per share are based on the weighted average number of common shares outstanding during the period. Diluted earnings per share are based on the weighted average number of common shares outstanding during the period adjusted to give effect to common stock equivalents.

The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):


	Three months ended March 31,
	2014			2013
Basic and Diluted:
Net income attributable to UHS	$	138,078		$	119,784
Less: Net income attributable to unvested restricted share grants		(70	)		(69	)

Net income attributable to UHS - basic and diluted	$	138,008		$	119,715

Weighted average number of common shares - basic		98,572			97,711
Net effect of dilutive stock options and grants based on the treasury stock method		1,585			860

Weighted average number of common shares and equivalents - diluted		100,157			98,571



Earnings per basic share attributable to UHS:	$	1.40		$	1.23



Earnings per diluted share attributable to UHS:	$	1.38		$	1.21

The “Net effect of dilutive stock options and grants based on the treasury stock method”, for all periods presented above, excludes certain outstanding stock options applicable to each period since the effect would have been anti-dilutive. There were no anti-dilutive stock options during the three months ended March 31, 2014 and March 31, 2013, respectively. All classes of our common stock have the same dividend rights.

Stock-Based Compensation: During the three-month periods ended March 31, 2014 and 2013, compensation cost of $6.8 million ($4.3 million after-tax) and $6.7 million ($4.2 million after-tax), respectively, was recognized related to outstanding stock options. In addition, during the three-month periods ended March 31, 2014 and 2013, compensation cost of approximately $409,000 ($256,000 after-tax) and $405,000 ($252,000 after-tax), respectively, was recognized related to restricted stock. As of March 31, 2014 there was $72.5 million of unrecognized compensation cost related to unvested options and restricted stock which is expected to be recognized over the remaining weighted average vesting period of 3.1 years. There were 2,772,100 stock options granted (net of cancellations) during the first three months of 2014 with a weighted-average grant date fair value of $17.12 per share.

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities and aggregated to $7.2 million and $7.1 million during the three-month periods ended March 31, 2014 and 2013, respectively. In accordance with ASC 718, excess income tax benefits related to stock based compensation are classified as cash inflows from financing activities on the Consolidated Statement of Cash Flows. Previously for the three-month period ended March 31, 2013, we included $9.3 million of excess income tax benefits related to stock based compensation as net cash provided by operating activities as included in the change in accrued and deferred income taxes for that period. In our Consolidated Statements of Cash Flows, as included herein, that amount is reflected as cash inflows from financing activities for the 2013 three-month period. We assessed this misclassification and concluded that it was not material to our previously issued quarterly Consolidated Statements of Cash Flows. During the first quarter of 2014, we generated $11.8 million of excess income tax benefits related to stock based compensation which are reflected as cash inflows from financing activities in our Consolidated Statements of Cash Flows.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References+ Details

Dispositions and acquisitions

3 Months Ended

Mar. 31, 2014

Dispositions and acquisitions

(8) Dispositions and acquisitions

Three-month periods ended March 31, 2014 and 2013:

Acquisitions:

Subsequent to March 31, 2014, we acquired the Psychiatric Institute of Washington, a 124-bed behavioral health care facility and outpatient treatment center located in Washington, D.C. As part of this transaction, we also acquired the Arbor Group, L.L.C., which operates three management contracts covering 66 beds in the Washington, D.C. and Maryland market.

During the first quarter of 2014, we paid approximately $3 million to acquire the operations of Palo Verde Behavioral Health, a 48-bed behavioral health care facility located in Tucson, Arizona.

There were no acquisitions during the first quarter of 2013.

Divestitures:

During the first quarter of 2014, we received approximately $11 million of cash proceeds for the divestiture of a non-operating investment. This transaction resulted in a pre-tax gain of approximately $10 million which is included in our consolidated results of operations during the first quarter of 2014.

During the first quarter of 2013, we received aggregate cash proceeds of approximately $7 million for the divestiture of certain real property, including two previously closed facilities. The pre-tax net gain on these divestitures did not have a material impact on our consolidated results of operations during the first quarter of 2013.

Income Taxes

3 Months Ended

Mar. 31, 2014

Income Taxes

(10) Income Taxes

As of January 1, 2014, our unrecognized tax benefits were approximately $3 million. The amount, if recognized, that would affect the effective tax rate is approximately $2 million. During the quarter ended March 31, 2014, changes to the estimated liabilities for uncertain tax positions (including accrued interest) relating to tax positions taken during prior and current periods did not have a material impact on our financial statements.

We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision. As of March 31, 2014, we have less than $1 million of accrued interest and penalties. The U.S. federal statute of limitations remains open for the 2010 and subsequent years. Foreign and U.S. state and local jurisdictions have statutes of limitations generally ranging from 3 to 4 years. The statute of limitations on certain jurisdictions could expire within the next twelve months. It is reasonably possible that the amount of uncertain tax benefits will change during the next 12 months, however, it is anticipated that any such change, if it were to occur, would not have a material impact on our result of operations.

We operate in multiple jurisdictions with varying tax laws. We are subject to audits by any of these taxing authorities. Our tax returns have been examined by the Internal Revenue Service (“IRS”) through the year ended December 31, 2006. We believe that adequate accruals have been provided for federal, foreign and state taxes.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References+ Details

Supplemental Condensed Consolidating Financial Information

3 Months Ended

Mar. 31, 2014

Supplemental Condensed Consolidating Financial Information

(11) Supplemental Condensed Consolidating Financial Information

Certain of our senior notes are guaranteed by a group of subsidiaries (the “Guarantors”). The Guarantors, each of which is a 100% directly owned subsidiary of Universal Health Services, Inc., fully and unconditionally guarantee the senior notes on a joint and several basis, subject to certain customary release provisions.

The following financial statements present condensed consolidating financial data for (i) Universal Health Services, Inc. (on a parent company only basis), (ii) the combined Guarantors, (iii) the combined non guarantor subsidiaries (all other subsidiaries), (iv) an elimination column for adjustments to arrive at the information for the parent company, Guarantors, and non guarantors on a consolidated basis, and (v) the parent company and our subsidiaries on a consolidated basis.

Investments in subsidiaries are accounted for by the parent company and the Guarantors using the equity method for this presentation. Results of operations of subsidiaries are therefore classified in the parent company’s and Guarantors’ investment in subsidiaries accounts. The elimination entries set forth in the following condensed consolidating financial statements eliminate distributed and undistributed income of subsidiaries, investments in subsidiaries, and intercompany balances and transactions between the parent, Guarantors, and non guarantors.

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts

Net revenues before provision for doubtful accounts	$	0		$	1,463,920		$	671,587		$	(7,157	)	$	2,128,350
Less: Provision for doubtful accounts		0			135,986			72,198			0			208,184

Net revenues		0			1,327,934			599,389			(7,157	)		1,920,166


Operating charges:
Salaries, wages and benefits		0			669,253			266,112			0			935,365
Other operating expenses		0			240,176			148,525			(6,941	)		381,760
Supplies expense		0			131,475			84,323			0			215,798
EHR incentive income		0			(430	)		0			0			(430	)
Depreciation and amortization		0			67,714			25,645			0			93,359
Lease and rental expense		0			14,349			9,205			(216	)		23,338

		0			1,122,537			533,810			(7,157	)		1,649,190


Income from operations		0			205,397			65,579			0			270,976
Interest expense		33,573			824			796			0			35,193
Interest (income) expense, affiliate		0			22,112			(22,112	)		0			0
Equity in net income of consolidated affiliates		(158,801	)		(42,952	)		0			201,753			0

Income before income taxes		125,228			225,413			86,895			(201,753	)		235,783
Provision for income taxes		(12,850	)		78,753			18,028			0			83,931

Net income		138,078			146,660			68,867			(201,753	)		151,852
Less: Income attributable to noncontrolling interests		0			0			13,774			0			13,774

Net income attributable to UHS	$	138,078		$	146,660		$	55,093		$	(201,753	)	$	138,078

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2013

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts

Net revenues before provision for doubtful accounts	$	0		$	1,421,852		$	663,206		$	(6,710	)	$	2,078,348
Less: Provision for doubtful accounts		0			149,768			96,948			0			246,716

Net revenues		0			1,272,084			566,258			(6,710	)		1,831,632


Operating charges:
Salaries, wages and benefits		0			645,594			256,702			0			902,296
Other operating expenses		0			244,419			143,203			(6,615	)		381,007
Supplies expense		0			128,710			75,932			0			204,642
Depreciation and amortization		0			55,779			24,033			0			79,812
Lease and rental expense		0			15,675			9,085			(95	)		24,665
EHR incentive income		0			(3,116	)		(1,596	)		0			(4,712	)

		0			1,087,061			507,359			(6,710	)		1,587,710


Income from operations		0			185,023			58,899			0			243,922
Interest expense		37,946			854			1,138			0			39,938
Interest (income) expense, affiliate		0			24,391			(24,391	)		0			0
Equity in net income of consolidated affiliates		(143,206	)		(31,781	)		0			174,987			0

Income before income taxes		105,260			191,559			82,152			(174,987	)		203,984
Provision for income taxes		(14,524	)		65,323			23,250			0			74,049

Net income		119,784			126,236			58,902			(174,987	)		129,935
Less: Income attributable to noncontrolling interests		0			0			10,151			0			10,151

Net income attributable to UHS	$	119,784		$	126,236		$	48,751		$	(174,987	)	$	119,784

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2014

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts

Net income	$	138,078		$	146,660	$	68,867	$	(201,753	)	$	151,852
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		3,745			0		0		0			3,745
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		3,661			0		0		0			3,661
Income tax expense related to items of other comprehensive income		1,354			0		0		0			1,354

Total other comprehensive income, net of tax		2,307			0		0		0			2,307


Comprehensive income		140,385			146,660		68,867		(201,753	)		154,159
Less: Comprehensive income attributable to noncontrolling interests		0			0		13,774		0			13,774

Comprehensive income attributable to UHS	$	140,385		$	146,660	$	55,093	$	(201,753	)	$	140,385

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2013

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts

Net income	$	119,784		$	126,236	$	58,902	$	(174,987	)	$	129,935
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		4,535			0		0		0			4,535
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		4,451			0		0		0			4,451
Income tax expense related to items of other comprehensive income		1,678			0		0		0			1,678

Total other comprehensive income, net of tax		2,773			0		0		0			2,773


Comprehensive income		122,557			126,236		58,902		(174,987	)		132,708
Less: Comprehensive income attributable to noncontrolling interests		0			0		10,151		0			10,151

Comprehensive income attributable to UHS	$	122,557		$	126,236	$	48,751	$	(174,987	)	$	122,557

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF MARCH 31, 2014

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	7,719		$	8,542		$	0		$	16,261
Accounts receivable, net		0		864,487			348,107			0			1,212,594
Supplies		0		63,952			38,324			0			102,276
Other current assets		0		85,134			12,551			0			97,685
Deferred income taxes		71,108		43,189			0			0			114,297

Total current assets		71,108		1,064,481			407,524			0			1,543,113


Investments in subsidiaries		6,537,300		1,519,863			0			(8,057,163	)		0
Intercompany receivable		205,674		0			443,751			(649,425	)		0
Intercompany note receivable		0		0			1,104,881			(1,104,881	)		0

Property and equipment		0		4,171,728			1,617,665			0			5,789,393
Less: accumulated depreciation		0		(1,532,857	)		(788,364	)		0			(2,321,221	)

		0		2,638,871			829,301			0			3,468,172


Other assets:
Goodwill		0		2,553,615			500,051			0			3,053,666
Deferred charges		45,425		5,683			2,413			0			53,521
Other		7,923		243,381			61,609			0			312,913

	$	6,867,430	$	8,025,894		$	3,349,530		$	(9,811,469	)	$	8,431,385


Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	101,903	$	916		$	822		$	0		$	103,641
Accounts payable and accrued liabilities		38,901		822,487			93,514			0			954,902
Federal and state taxes		49,753		2,152			0			0			51,905

Total current liabilities		190,557		825,555			94,336			0			1,110,448


Intercompany payable		0		649,425			0			(649,425	)		0
Other noncurrent liabilities		4,202		200,091			77,880			0			282,173
Long-term debt		3,079,123		5,109			24,926			0			3,109,158
Intercompany note payable		0		1,104,881			0			(1,104,881	)		0
Deferred income taxes		201,429		55,915			0			0			257,344

Redeemable noncontrolling interests		0		0			228,107			0			228,107

UHS common stockholders’ equity		3,392,119		5,184,918			2,872,245			(8,057,163	)		3,392,119
Noncontrolling interest		0		0			52,036			0			52,036

Total equity		3,392,119		5,184,918			2,924,281			(8,057,163	)		3,444,155

	$	6,867,430	$	8,025,894		$	3,349,530		$	(9,811,469	)	$	8,431,385

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2013

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	7,990		$	9,248		$	0		$	17,238
Accounts receivable, net		0		799,898			317,063			0			1,116,961
Supplies		0		63,562			38,219			0			101,781
Deferred income taxes		76,719		43,184			0			0			119,903
Other current assets		0		63,786			12,660			0			76,446

Total current assets		76,719		978,420			377,190			0			1,432,329


Investments in subsidiaries		6,378,499		1,476,911			0			(7,855,410	)		0
Intercompany receivable		226,592		0			531,411			(758,003	)		0
Intercompany note receivable		0		0			982,568			(982,568	)		0

Property and equipment		0		4,093,914			1,597,988			0			5,691,902
Less: accumulated depreciation		0		(1,478,758	)		(770,975	)		0			(2,249,733	)

		0		2,615,156			827,013			0			3,442,169


Other assets:
Goodwill		0		2,552,190			496,826			0			3,049,016
Deferred charges		49,866		5,577			2,438			0			57,881
Other		8,411		251,365			70,552			0			330,328

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723


Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	97,403		916			993			0		$	99,312
Accounts payable and accrued liabilities		28,099		837,354			87,996			0			953,449
Federal and state taxes		4,963		2,164			0			0			7,127

Total current liabilities		130,465		840,434			88,989			0			1,059,888


Intercompany payable		0		758,003			0			(758,003	)		0
Other noncurrent liabilities		7,591		199,104			77,894			0			284,589
Long-term debt		3,168,819		5,337			35,606			0			3,209,762
Intercompany note payable		0		982,568			0			(982,568	)		0
Deferred income taxes		183,233		55,915			0			0			239,148

Redeemable noncontrolling interests		0		0			218,107			0			218,107

UHS common stockholders’ equity		3,249,979		5,038,258			2,817,152			(7,855,410	)		3,249,979
Noncontrolling interest		0		0			50,250			0			50,250

Total equity		3,249,979		5,038,258			2,867,402			(7,855,410	)		3,300,229

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MARCH 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts

Net cash provided by operating activities	$	70,888			51,661			72,090		$	0	$	194,639


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(70,385	)		(22,002	)		0		(92,387	)
Proceeds received from sale of assets and businesses		0			11,450			0			0		11,450
Acquisition of property and businesses		0			0			(3,301	)				(3,301	)
Costs incurred for purchase and implementation of electronic health records application		0			(6,504	)		0			0		(6,504	)

Net cash used in investing activities		0			(65,439	)		(25,303	)		0		(90,742	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(97,975	)		(228	)		(10,851	)		0		(109,054	)
Additional borrowings		11,900			0			0			0		11,900
Repurchase of common shares		(13,993	)		0			0			0		(13,993	)
Dividends paid		(4,933	)		0			0			0		(4,933	)
Issuance of common stock		1,445			0			0			0		1,445

Excess income tax benefits related to stock-based compensation		11,750			0			0			0		11,750
Profit distributions to noncontrolling interests		0			0			(1,989	)		0		(1,989	)
Changes in intercompany balances with affiliates, net		20,918			13,735			(34,653	)		0		0


Net cash (used in) provided by financing activities		(70,888	)		13,507			(47,493	)		0		(104,874	)


Decrease in cash and cash equivalents		0			(271	)		(706	)		0		(977	)
Cash and cash equivalents, beginning of period		0			7,990			9,248			0		17,238

Cash and cash equivalents, end of period	$	0		$	7,719		$	8,542		$	0	$	16,261

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MARCH 31, 2013

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts

Net cash provided by operating activities	$	64,747			35,367			78,383		$	0	$	178,497


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(54,822	)		(41,097	)		0		(95,919	)
Proceeds received from sale of assets and businesses		0			4,178			2,479			0		6,657
Acquisition of property and businesses		0			0			0					0
Costs incurred for purchase and implementation of electronic health records application		0			(16,412	)		0			0		(16,412	)

Net cash used in investing activities		0			(67,056	)		(38,618	)		0		(105,674	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(63,612	)		(265	)		(6,049	)		0		(69,926	)
Additional borrowings		9,500			0			0			0		9,500
Repurchase of common shares		(14,027	)		0			0			0		(14,027	)
Dividends paid		(4,870	)		0			0			0		(4,870	)
Issuance of common stock		1,232			0			0			0		1,232

Excess income tax benefits related to stock-based compensation		9,266			0			0			0		9,266
Profit distributions to noncontrolling interests		0			0			(10,074	)		0		(10,074	)
Changes in intercompany balances with affiliates, net		(2,236	)		28,322			(26,086	)		0		0


Net cash (used in) provided by financing activities		(64,747	)		28,057			(42,209	)		0		(78,899	)


Decrease in cash and cash equivalents		0			(3,632	)		(2,444	)		0		(6,076	)
Cash and cash equivalents, beginning of period		0			11,949			11,522			0		23,471

Cash and cash equivalents, end of period	$	0		$	8,317		$	9,078		$	0	$	17,395

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References+ Details

Recent Accounting Standards

3 Months Ended

Mar. 31, 2014

Recent Accounting Standards

(12) Recent Accounting Standards

In April 2014, the Financial Accounting Standards Board updated the accounting guidance related to the definition of a discontinued operation and the related disclosures. The updated accounting guidance defines a discontinued operation as a disposal of a component or a group of components that is to be disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity’s operations and financial results. The updated guidance is applicable to us effective January 1, 2015 with early adoption permitted. We do not expect the adoption of this update to have a material impact on our consolidated financial statements.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 01

-Paragraph b

-Subparagraph 6

-Article 10

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Direct Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6510796

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Indirect Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6515603

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accounting Change

-URI http://asc.fasb.org/extlink&oid=6503790

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6507316

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.10-01.(b)(6))

-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Retrospective Application

-URI http://asc.fasb.org/extlink&oid=6523989

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22583-107794

+ Details

Relationship with Universal Health Realty Income Trust and Related Party Transactions (Tables)

3 Months Ended

Mar. 31, 2014

Remaining Renewal Options and Terms for Each of Four Hospital Facilities Leased from Trust

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2014

Segment Reporting


	Three months ended March 31, 2014
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	3,876,364		$	1,608,899			—		$	5,485,263
Gross outpatient revenues	$	1,957,491		$	184,115		$	8,514		$	2,150,120
Total net revenues	$	971,391		$	945,457		$	3,318		$	1,920,166
Income/(loss) before allocation of corporate overhead and income taxes	$	111,650		$	221,148		($	97,015	)	$	235,783
Allocation of corporate overhead	($	44,697	)	($	26,169	)	$	70,866			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	66,953		$	194,979		($	26,149	)	$	235,783
Total assets as of 3/31/14	$	3,200,203		$	5,004,478		$	226,704		$	8,431,385


	Three months ended March 31, 2013
	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	3,507,270		$	1,576,148			—		$	5,083,418
Gross outpatient revenues	$	1,651,575		$	185,802		$	10,848		$	1,848,225
Total net revenues	$	908,734		$	909,544		$	13,354		$	1,831,632
Income/(loss) before allocation of corporate overhead and income taxes	$	80,629		$	220,775		($	97,420	)	$	203,984
Allocation of corporate overhead	($	46,112	)	($	22,367	)	$	68,479			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	34,517		$	198,408		($	28,941	)	$	203,984
Total assets as of 3/31/13	$	3,077,881		$	4,963,760		$	274,867		$	8,316,508

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details

Earnings Per Share Data ("EPS") and Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2014

Computation of Basic and Diluted Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):


	Three months ended March 31,
	2014			2013
Basic and Diluted:
Net income attributable to UHS	$	138,078		$	119,784
Less: Net income attributable to unvested restricted share grants		(70	)		(69	)

Net income attributable to UHS - basic and diluted	$	138,008		$	119,715

Weighted average number of common shares - basic		98,572			97,711
Net effect of dilutive stock options and grants based on the treasury stock method		1,585			860

Weighted average number of common shares and equivalents - diluted		100,157			98,571



Earnings per basic share attributable to UHS:	$	1.40		$	1.23



Earnings per diluted share attributable to UHS:	$	1.38		$	1.21

Supplemental Condensed Consolidating Financial Information (Tables)

3 Months Ended

Mar. 31, 2014

Condensed Consolidating Statements of Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts

Net revenues before provision for doubtful accounts	$	0		$	1,463,920		$	671,587		$	(7,157	)	$	2,128,350
Less: Provision for doubtful accounts		0			135,986			72,198			0			208,184

Net revenues		0			1,327,934			599,389			(7,157	)		1,920,166


Operating charges:
Salaries, wages and benefits		0			669,253			266,112			0			935,365
Other operating expenses		0			240,176			148,525			(6,941	)		381,760
Supplies expense		0			131,475			84,323			0			215,798
EHR incentive income		0			(430	)		0			0			(430	)
Depreciation and amortization		0			67,714			25,645			0			93,359
Lease and rental expense		0			14,349			9,205			(216	)		23,338

		0			1,122,537			533,810			(7,157	)		1,649,190


Income from operations		0			205,397			65,579			0			270,976
Interest expense		33,573			824			796			0			35,193
Interest (income) expense, affiliate		0			22,112			(22,112	)		0			0
Equity in net income of consolidated affiliates		(158,801	)		(42,952	)		0			201,753			0

Income before income taxes		125,228			225,413			86,895			(201,753	)		235,783
Provision for income taxes		(12,850	)		78,753			18,028			0			83,931

Net income		138,078			146,660			68,867			(201,753	)		151,852
Less: Income attributable to noncontrolling interests		0			0			13,774			0			13,774

Net income attributable to UHS	$	138,078		$	146,660		$	55,093		$	(201,753	)	$	138,078

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2013

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts

Net revenues before provision for doubtful accounts	$	0		$	1,421,852		$	663,206		$	(6,710	)	$	2,078,348
Less: Provision for doubtful accounts		0			149,768			96,948			0			246,716

Net revenues		0			1,272,084			566,258			(6,710	)		1,831,632


Operating charges:
Salaries, wages and benefits		0			645,594			256,702			0			902,296
Other operating expenses		0			244,419			143,203			(6,615	)		381,007
Supplies expense		0			128,710			75,932			0			204,642
Depreciation and amortization		0			55,779			24,033			0			79,812
Lease and rental expense		0			15,675			9,085			(95	)		24,665
EHR incentive income		0			(3,116	)		(1,596	)		0			(4,712	)

		0			1,087,061			507,359			(6,710	)		1,587,710


Income from operations		0			185,023			58,899			0			243,922
Interest expense		37,946			854			1,138			0			39,938
Interest (income) expense, affiliate		0			24,391			(24,391	)		0			0
Equity in net income of consolidated affiliates		(143,206	)		(31,781	)		0			174,987			0

Income before income taxes		105,260			191,559			82,152			(174,987	)		203,984
Provision for income taxes		(14,524	)		65,323			23,250			0			74,049

Net income		119,784			126,236			58,902			(174,987	)		129,935
Less: Income attributable to noncontrolling interests		0			0			10,151			0			10,151

Net income attributable to UHS	$	119,784		$	126,236		$	48,751		$	(174,987	)	$	119,784

Condensed Consolidating Statements of Comprehensive Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2014

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts

Net income	$	138,078		$	146,660	$	68,867	$	(201,753	)	$	151,852
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		3,745			0		0		0			3,745
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		3,661			0		0		0			3,661
Income tax expense related to items of other comprehensive income		1,354			0		0		0			1,354

Total other comprehensive income, net of tax		2,307			0		0		0			2,307


Comprehensive income		140,385			146,660		68,867		(201,753	)		154,159
Less: Comprehensive income attributable to noncontrolling interests		0			0		13,774		0			13,774

Comprehensive income attributable to UHS	$	140,385		$	146,660	$	55,093	$	(201,753	)	$	140,385

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2013

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts

Net income	$	119,784		$	126,236	$	58,902	$	(174,987	)	$	129,935
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		4,535			0		0		0			4,535
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		4,451			0		0		0			4,451
Income tax expense related to items of other comprehensive income		1,678			0		0		0			1,678

Total other comprehensive income, net of tax		2,773			0		0		0			2,773


Comprehensive income		122,557			126,236		58,902		(174,987	)		132,708
Less: Comprehensive income attributable to noncontrolling interests		0			0		10,151		0			10,151

Comprehensive income attributable to UHS	$	122,557		$	126,236	$	48,751	$	(174,987	)	$	122,557

Condensed Consolidating Balance Sheet

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF MARCH 31, 2014

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	7,719		$	8,542		$	0		$	16,261
Accounts receivable, net		0		864,487			348,107			0			1,212,594
Supplies		0		63,952			38,324			0			102,276
Other current assets		0		85,134			12,551			0			97,685
Deferred income taxes		71,108		43,189			0			0			114,297

Total current assets		71,108		1,064,481			407,524			0			1,543,113


Investments in subsidiaries		6,537,300		1,519,863			0			(8,057,163	)		0
Intercompany receivable		205,674		0			443,751			(649,425	)		0
Intercompany note receivable		0		0			1,104,881			(1,104,881	)		0

Property and equipment		0		4,171,728			1,617,665			0			5,789,393
Less: accumulated depreciation		0		(1,532,857	)		(788,364	)		0			(2,321,221	)

		0		2,638,871			829,301			0			3,468,172


Other assets:
Goodwill		0		2,553,615			500,051			0			3,053,666
Deferred charges		45,425		5,683			2,413			0			53,521
Other		7,923		243,381			61,609			0			312,913

	$	6,867,430	$	8,025,894		$	3,349,530		$	(9,811,469	)	$	8,431,385


Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	101,903	$	916		$	822		$	0		$	103,641
Accounts payable and accrued liabilities		38,901		822,487			93,514			0			954,902
Federal and state taxes		49,753		2,152			0			0			51,905

Total current liabilities		190,557		825,555			94,336			0			1,110,448


Intercompany payable		0		649,425			0			(649,425	)		0
Other noncurrent liabilities		4,202		200,091			77,880			0			282,173
Long-term debt		3,079,123		5,109			24,926			0			3,109,158
Intercompany note payable		0		1,104,881			0			(1,104,881	)		0
Deferred income taxes		201,429		55,915			0			0			257,344

Redeemable noncontrolling interests		0		0			228,107			0			228,107

UHS common stockholders’ equity		3,392,119		5,184,918			2,872,245			(8,057,163	)		3,392,119
Noncontrolling interest		0		0			52,036			0			52,036

Total equity		3,392,119		5,184,918			2,924,281			(8,057,163	)		3,444,155

	$	6,867,430	$	8,025,894		$	3,349,530		$	(9,811,469	)	$	8,431,385

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2013

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	7,990		$	9,248		$	0		$	17,238
Accounts receivable, net		0		799,898			317,063			0			1,116,961
Supplies		0		63,562			38,219			0			101,781
Deferred income taxes		76,719		43,184			0			0			119,903
Other current assets		0		63,786			12,660			0			76,446

Total current assets		76,719		978,420			377,190			0			1,432,329


Investments in subsidiaries		6,378,499		1,476,911			0			(7,855,410	)		0
Intercompany receivable		226,592		0			531,411			(758,003	)		0
Intercompany note receivable		0		0			982,568			(982,568	)		0

Property and equipment		0		4,093,914			1,597,988			0			5,691,902
Less: accumulated depreciation		0		(1,478,758	)		(770,975	)		0			(2,249,733	)

		0		2,615,156			827,013			0			3,442,169


Other assets:
Goodwill		0		2,552,190			496,826			0			3,049,016
Deferred charges		49,866		5,577			2,438			0			57,881
Other		8,411		251,365			70,552			0			330,328

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723


Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	97,403		916			993			0		$	99,312
Accounts payable and accrued liabilities		28,099		837,354			87,996			0			953,449
Federal and state taxes		4,963		2,164			0			0			7,127

Total current liabilities		130,465		840,434			88,989			0			1,059,888


Intercompany payable		0		758,003			0			(758,003	)		0
Other noncurrent liabilities		7,591		199,104			77,894			0			284,589
Long-term debt		3,168,819		5,337			35,606			0			3,209,762
Intercompany note payable		0		982,568			0			(982,568	)		0
Deferred income taxes		183,233		55,915			0			0			239,148

Redeemable noncontrolling interests		0		0			218,107			0			218,107

UHS common stockholders’ equity		3,249,979		5,038,258			2,817,152			(7,855,410	)		3,249,979
Noncontrolling interest		0		0			50,250			0			50,250

Total equity		3,249,979		5,038,258			2,867,402			(7,855,410	)		3,300,229

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

Condensed Consolidating Statements of Cash Flows

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MARCH 31, 2014

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts

Net cash provided by operating activities	$	70,888			51,661			72,090		$	0	$	194,639


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(70,385	)		(22,002	)		0		(92,387	)
Proceeds received from sale of assets and businesses		0			11,450			0			0		11,450
Acquisition of property and businesses		0			0			(3,301	)				(3,301	)
Costs incurred for purchase and implementation of electronic health records application		0			(6,504	)		0			0		(6,504	)

Net cash used in investing activities		0			(65,439	)		(25,303	)		0		(90,742	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(97,975	)		(228	)		(10,851	)		0		(109,054	)
Additional borrowings		11,900			0			0			0		11,900
Repurchase of common shares		(13,993	)		0			0			0		(13,993	)
Dividends paid		(4,933	)		0			0			0		(4,933	)
Issuance of common stock		1,445			0			0			0		1,445

Excess income tax benefits related to stock-based compensation		11,750			0			0			0		11,750
Profit distributions to noncontrolling interests		0			0			(1,989	)		0		(1,989	)
Changes in intercompany balances with affiliates, net		20,918			13,735			(34,653	)		0		0


Net cash (used in) provided by financing activities		(70,888	)		13,507			(47,493	)		0		(104,874	)


Decrease in cash and cash equivalents		0			(271	)		(706	)		0		(977	)
Cash and cash equivalents, beginning of period		0			7,990			9,248			0		17,238

Cash and cash equivalents, end of period	$	0		$	7,719		$	8,542		$	0	$	16,261

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MARCH 31, 2013

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts

Net cash provided by operating activities	$	64,747			35,367			78,383		$	0	$	178,497


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(54,822	)		(41,097	)		0		(95,919	)
Proceeds received from sale of assets and businesses		0			4,178			2,479			0		6,657
Acquisition of property and businesses		0			0			0					0
Costs incurred for purchase and implementation of electronic health records application		0			(16,412	)		0			0		(16,412	)

Net cash used in investing activities		0			(67,056	)		(38,618	)		0		(105,674	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(63,612	)		(265	)		(6,049	)		0		(69,926	)
Additional borrowings		9,500			0			0			0		9,500
Repurchase of common shares		(14,027	)		0			0			0		(14,027	)
Dividends paid		(4,870	)		0			0			0		(4,870	)
Issuance of common stock		1,232			0			0			0		1,232

Excess income tax benefits related to stock-based compensation		9,266			0			0			0		9,266
Profit distributions to noncontrolling interests		0			0			(10,074	)		0		(10,074	)
Changes in intercompany balances with affiliates, net		(2,236	)		28,322			(26,086	)		0		0


Net cash (used in) provided by financing activities		(64,747	)		28,057			(42,209	)		0		(78,899	)


Decrease in cash and cash equivalents		0			(3,632	)		(2,444	)		0		(6,076	)
Cash and cash equivalents, beginning of period		0			11,949			11,522			0		23,471

Cash and cash equivalents, end of period	$	0		$	8,317		$	9,078		$	0	$	17,395

Relationship with Universal Health Realty Income Trust and Related Party Transactions - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies	$ 25,000,000
Chief Executive Officer \| Minimum
Related Party Transaction [Line Items]
Estimated death benefit proceeds	33,000,000
Chief Executive Officer \| Trust Owned by Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies	8,000,000
Relationship with Universal Health Realty Income Trust
Related Party Transaction [Line Items]
Trust outstanding shares held, percentage	6.10%
Advisory fee earned	600,000	600,000
Pre-tax share of income from the Trust	300,000	300,000
Carrying value of investment in Trust	8,000,000	8,000,000
Market value of investment in Trust	33,000,000	32,000,000
Rent expense under operating leases	$ 4,000,000	$ 4,000,000
Non-controlling ownership interests by subsidiaries	100.00%

Remaining Renewal Options and Terms for Hospital Facilities Leased from Trust (Detail) (USD $)
In Thousands, unless otherwise specified

3 Months Ended

Mar. 31, 2014

McAllen Medical Center

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

$ 5,485

2016-12

15 years

^[1]

Wellington Regional Medical Center

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

3,030

2016-12

15 years

^[2]

Southwest Healthcare System, Inland Valley Campus

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

2,648

2016-12

15 years

^[2]

The Bridgeway

Property Subject to or Available for Operating Lease [Line Items]

Behavioral Health

$ 930

2014-12

10 years

^[3]

[1]	We have three 5-year renewal options at existing lease rates (through 2031).
[2]	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
[3]	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Remaining Renewal Options and Terms for Hospital Facilities Leased from Trust (Parenthetical) (Detail)	3 Months Ended
	Mar. 31, 2014 RenewalOptions
McAllen Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	3
Renewal options term at existing lease rates	5 years
Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	2
Renewal options term at existing lease rates	5 years
The Bridgeway
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	2
Renewal options term at existing lease rates	5 years
Maximum \| McAllen Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2031
Maximum \| Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| The Bridgeway
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2024
Minimum \| Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| The Bridgeway
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2015

Other Noncurrent Liabilities and Redeemable/Noncontrolling Interests - Additional Information (Detail) (USD $)			3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014 Acute Care Hospital Services Las Vegas, Nevada Facility	Mar. 31, 2014 Acute Care Hospital Services Washington, District of Columbia	Mar. 31, 2014 Acute Care Hospital Services Laredo, Texas	Mar. 31, 2014 Behavioral Health Services Philadelphia, Pennsylvania
Noncontrolling Interest [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners			28.00%	20.00%	11.00%	20.00%
Number of facilities			5
Redeemable noncontrolling interests	$ 228,000,000	$ 218,000,000
Noncontrolling interest balance	$ 52,036,000	$ 50,250,000

- Definition

As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.

+ References+ Details

Long-term debt and cash flow hedges - Additional Information (Detail) (USD $)	3 Months Ended		12 Months Ended				3 Months Ended			12 Months Ended			1 Months Ended	3 Months Ended	1 Months Ended			3 Months Ended																					1 Months Ended						1 Months Ended	3 Months Ended										3 Months Ended							1 Months Ended		3 Months Ended		3 Months Ended
	Mar. 31, 2014	Mar. 31, 2011 Derivative	Dec. 31, 2010 Derivative	Dec. 31, 2013	Oct. 31, 2013	Mar. 31, 2011 One Point Nine One Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 Two Point Five Zero Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 One Point Nine Six Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 One Point Three Two Percent Forward Starting Interest Rate Swaps	Dec. 31, 2010 Two Point Three Eight Percent Forward Starting Interest Rate Swaps	Mar. 31, 2014 Interest Rate Swap	Dec. 31, 2013 Interest Rate Swap	Sep. 29, 2010 7.00% Senior Unsecured Notes	Mar. 31, 2014 7.00% Senior Unsecured Notes	Sep. 29, 2010 7.00% Senior Unsecured Notes Debtor Optional Redemption Period 1	Sep. 29, 2010 7.00% Senior Unsecured Notes Debtor Optional Redemption Period 2	Sep. 29, 2010 7.00% Senior Unsecured Notes Debtor Optional Redemption Period 3	Mar. 31, 2014 Senior Notes 7.125%	Jun. 30, 2008 Senior Notes 7.125%	Jun. 30, 2006 Senior Notes 7.125%	Mar. 31, 2014 Accounts Receivable Securitization Facility	Mar. 31, 2014 Accounts Payable and Accrued Liabilities Interest Rate Swap	Dec. 31, 2013 Accounts Payable and Accrued Liabilities Interest Rate Swap	Mar. 31, 2014 Other Noncurrent Liabilities Interest Rate Swap	Dec. 31, 2013 Other Noncurrent Liabilities Interest Rate Swap	Mar. 31, 2011 Cash Flow Hedging Forward Starting Interest Rate Swaps	Mar. 31, 2011 Cash Flow Hedging One Point Nine One Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 Cash Flow Hedging Two Point Five Zero Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 Cash Flow Hedging One Point Nine Six Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 Cash Flow Hedging One Point Three Two Percent Forward Starting Interest Rate Swaps	Dec. 31, 2010 Cash Flow Hedging Two Point Three Eight Percent Forward Starting Interest Rate Swaps	Mar. 31, 2014 ABR-based loans	Mar. 31, 2014 Amendment of Credit Facility	Mar. 31, 2014 Term Loan- A2	Mar. 31, 2014 Term Loan- A2 One Month Eurodollar Rate Plus Index Based Loans Minimum	Mar. 31, 2014 Term Loan- A2 One Month Eurodollar Rate Plus Index Based Loans Maximum	Mar. 31, 2014 Term Loan- A2 One Two Three Six Month Eurodollar Rate Plus Index Based Loans Minimum	Mar. 31, 2014 Term Loan- A2 One Two Three Six Month Eurodollar Rate Plus Index Based Loans Maximum	Sep. 30, 2012 Term Loan- A2 Amendment of Credit Facility	Mar. 31, 2014 Term Loan- A2 Amendment of Credit Facility	Mar. 31, 2014 Term Loan B Facility	Mar. 31, 2014 Term Loan B Facility One Month Eurodollar Rate Plus Index Based Loans	Mar. 31, 2014 Term Loan B Facility One Two Three Six Month Eurodollar Rate Plus Index Based Loans	Mar. 31, 2014 Term Loan B Facility Amendment of Credit Facility	May 31, 2013 Term Loan B Facility Amendment of Credit Facility Minimum	Mar. 31, 2014 Revolving Credit Facility	Sep. 30, 2012 Revolving Credit Facility	Mar. 31, 2014 Revolving Credit Facility One Month Eurodollar Rate Plus Index Based Loans Minimum	Mar. 31, 2014 Revolving Credit Facility One Month Eurodollar Rate Plus Index Based Loans Maximum	Mar. 31, 2014 Revolving Credit Facility One Two Three Six Month Eurodollar Rate Plus Index Based Loans	Mar. 31, 2014 Revolving Credit Facility One Two Three Six Month Eurodollar Rate Plus Index Based Loans Maximum	Mar. 31, 2014 Revolving Credit Facility Amendment of Credit Facility	Nov. 15, 2010 Revolving Credit Facility Amendment of Credit Facility	Mar. 31, 2014 Revolving Credit Facility Amendment of Credit Facility Extended Maturity	Sep. 30, 2012 Revolving Credit Facility Amendment of Credit Facility Extended Maturity	Mar. 31, 2014 Term Loan A	Sep. 30, 2012 Term Loan A	Mar. 31, 2014 Term Loan A One Month Eurodollar Rate Plus Index Based Loans Minimum	Mar. 31, 2014 Term Loan A One Month Eurodollar Rate Plus Index Based Loans Maximum	Mar. 31, 2014 Term Loan A One Two Three Six Month Eurodollar Rate Plus Index Based Loans Minimum	Mar. 31, 2014 Term Loan A One Two Three Six Month Eurodollar Rate Plus Index Based Loans Maximum	Mar. 31, 2014 Term Loan A Amendment of Credit Facility	Sep. 30, 2012 Term Loan A Amendment of Credit Facility Extended Maturity	May 31, 2013 Tranche B-1 Term Loan Amendment of Credit Facility	Mar. 31, 2014 Tranche B-1 Term Loan Amendment of Credit Facility	Mar. 31, 2014 Short Term on Demand Credit Facility	Mar. 31, 2014 Term Loan-A and Term Loan A2 facilities	Mar. 31, 2013 Term Loan-A and Term Loan A2 facilities
Debt Instrument [Line Items]
Line of credit facility, borrowing capacity																																														$ 800,000,000							$ 800,000,000											$ 745,900,000
Term loan interest rate description																																																																	Borrowings under the Tranche B-1 term loan, which totaled $550 million as of March 31, 2014, bear interest at a rate per annum equal to, at our election, one, two, three or six month LIBOR, plus an applicable margin of 2.25% or ABR plus an applicable margin of 1.25%
Applicable margin percentage on LIBOR																																																																2.25%
Applicable margin percentage on ABR																																																																1.25%
Minimum LIBOR rate for term loan eliminated																																													1.00%
Minimum ABR rate for term loan eliminated																																													2.00%
Line of credit facility amount outstanding																																	3,140,000,000							866,000,000				550,000,000		7,000,000						800,000,000		7,000,000	777,000,000							926,000,000	884,000,000		550,000,000	30,000,000
Borrowing outstanding																																								866,000,000
Line of credit facility, maturity date																																							Aug. 15, 2016							Nov. 15, 2015										Nov. 15, 2015							Aug. 15, 2016
Line of credit facility, available borrowing capacity																																														743,000,000	23,000,000										42,000,000
Letters of credit, outstanding																																	125,000,000													20,000,000
Rate adjustment to weighted average federal funds rate for credit facility borrowings	0.50%
Rate adjustment to one month Eurodollar rate on credit facility borrowings	1.00%
Consolidated leverage ratio																																			0.50%	1.25%	1.50%	2.25%				1.25%	2.25%					0.50%	1.25%	1.50%	2.25%							0.50%	1.25%	1.50%	2.25%
Current applicable margins																																0.50%		1.50%							2.25%					1.50%										1.50%
Scheduled principal payments made																																																																			18,000,000	18,000,000
Installment payments due																																									0																										54,000,000
Quarterly installment payments due in 2015																																																																			77,000,000
Quarterly installment payments due in 2016																																																																			46,000,000
Accounts receivable securitization program credit facility, borrowing capacity					275,000,000
Accounts receivable securitization program credit facility, amount outstanding	160,000,000
Accounts receivable securitization program, additional capacity																					115,000,000
Senior notes, issued													250,000,000							250,000,000
Senior notes, interest rate													7.00%							7.125%
Senior notes, maturity date														Oct. 01, 2018				Jun. 30, 2016
Unsecured Notes make-whole redemption price															103.50%	101.75%	100.00%
Treasury rate plus, basis points													0.50%
Senior notes, repayment terms														Payable semiannually in arrears on April 1st and October 1st of each year				Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year
Line of credit facility additional borrowing capacity																			150,000,000
Fair value of debt	3,300,000,000
Long-term debt	3,109,158,000			3,209,762,000
Number of additional forward starting interest rate swaps		6	4
Notional amount of interest rate cash flow hedges																										425,000,000	225,000,000	100,000,000	25,000,000	75,000,000	600,000,000
Average fixed rate payable on interest rate swap						1.91%
Fixed rate payable on interest rate swap							2.50%	1.96%	1.32%	2.38%
Maturity date of interest rate cash flow hedges							Dec. 01, 2014	Dec. 01, 2013	Dec. 01, 2012	May 01, 2015
Fair value of our interest rate swaps, liability											$ 20,000,000	$ 24,000,000										$ 18,000,000	$ 19,000,000	$ 2,000,000	$ 5,000,000

Commitments and Contingencies - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014 Letters of Credit and Surety Bonds	Mar. 31, 2014 Self Insurance Programs Letters of Credit and Surety Bonds	Mar. 31, 2014 Other Debt Guarantees Letters of Credit and Surety Bonds	Mar. 31, 2014 Location 2	Mar. 31, 2014 Location 1	Mar. 31, 2014 Illinois	Dec. 31, 2013 Illinois	Mar. 31, 2014 Wind Storms Minimum	Mar. 31, 2014 Wind Storms Maximum	Mar. 31, 2014 Earthquake	Mar. 31, 2014 Earthquake Maximum	Mar. 31, 2014 Earthquake UNITED STATES Minimum	Mar. 31, 2014 Earthquake UNITED STATES Maximum	Mar. 31, 2014 Earthquake PUERTO RICO	Mar. 31, 2014 Flood Location 2	Mar. 31, 2014 Flood Location 1	Nov. 30, 2010 Subsidiaries Professional Liability Maximum	Nov. 30, 2010 Subsidiaries General Liability Maximum	Mar. 31, 2014 Subsidiaries General and Professional Liability Insurance Policies	Mar. 31, 2014 Subsidiaries General and Professional Liability Insurance Policies Minimum	Mar. 31, 2014 Subsidiaries General and Professional Liability Insurance Policies Maximum	Mar. 31, 2014 Psychiatric Solutions Inc General and Professional Liability Insurance Policies Maximum	Oct. 30, 2012 Behavioral Health Facilities Acquired from Ascend Health Corporation General and Professional Liability Insurance Policies	Oct. 30, 2012 Behavioral Health Facilities Acquired from Ascend Health Corporation General and Professional Liability Insurance Policies Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability	$ 206,000,000	$ 206,000,000																	$ 10,000,000	$ 3,000,000				$ 3,000,000		$ 20,000,000
Purchased several excess policies through commercial insurance carriers per occurrence																							250,000,000			250,000,000
Percentage of liability for claims paid under commercially insured coverage																					10.00%
Liability for claims paid under commercially insured coverage																						10,000,000	60,000,000
Minimum Insurance Deductible						250,000	50,000					250,000													25,000
Self-insured for professional and general liability, current	44,000,000	44,000,000
Compensation liability claims	65,000,000	64,000,000
Compensation and related benefits	34,000,000	34,000,000
Commercial property insurance policies covering catastrophic losses											1,000,000,000		250,000,000		100,000,000	25,000,000
Percentage of insurance deductible										3.00%	5.00%			1.00%	5.00%
Maximum insurance deductible																25,000	250,000	500,000
Accounts receivable, net	1,212,594,000	1,116,961,000						39,000,000	49,000,000
Accounts receivable net greater than sixty days Past due								14,000,000	28,000,000
Accounts receivable								40,000,000	46,000,000
Off-balance sheet contingent obligation			$ 90,000,000	$ 73,000,000	$ 17,000,000

Segment Reporting (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Segment Reporting Information [Line Items]
Gross inpatient revenues	$ 5,485,263	$ 5,083,418
Gross outpatient revenues	2,150,120	1,848,225
Total net revenues	1,920,166	1,831,632
Income/(loss) before allocation of corporate overhead and income taxes	235,783	203,984
Allocation of corporate overhead	0	0
Income/(loss) after allocation of corporate overhead and before income taxes	235,783	203,984
Total assets	8,431,385	8,316,508	8,311,723
Acute Care Hospital Services
Segment Reporting Information [Line Items]
Gross inpatient revenues	3,876,364	3,507,270
Gross outpatient revenues	1,957,491	1,651,575
Total net revenues	971,391	908,734
Income/(loss) before allocation of corporate overhead and income taxes	111,650	80,629
Allocation of corporate overhead	(44,697)	(46,112)
Income/(loss) after allocation of corporate overhead and before income taxes	66,953	34,517
Total assets	3,200,203	3,077,881
Behavioral Health Services
Segment Reporting Information [Line Items]
Gross inpatient revenues	1,608,899	1,576,148
Gross outpatient revenues	184,115	185,802
Total net revenues	945,457	909,544
Income/(loss) before allocation of corporate overhead and income taxes	221,148	220,775
Allocation of corporate overhead	(26,169)	(22,367)
Income/(loss) after allocation of corporate overhead and before income taxes	194,979	198,408
Total assets	5,004,478	4,963,760
Other
Segment Reporting Information [Line Items]
Gross outpatient revenues	8,514	10,848
Total net revenues	3,318	13,354
Income/(loss) before allocation of corporate overhead and income taxes	(97,015)	(97,420)
Allocation of corporate overhead	70,866	68,479
Income/(loss) after allocation of corporate overhead and before income taxes	(26,149)	(28,941)
Total assets	$ 226,704	$ 274,867

Computation of Basic and Diluted Earnings per Share (Detail) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Basic and Diluted:
Net income attributable to UHS	$ 138,078	$ 119,784
Less: Net income attributable to unvested restricted share grants	(70)	(69)
Net income attributable to UHS - basic and diluted	$ 138,008	$ 119,715
Weighted average number of common shares - basic	98,572	97,711
Net effect of dilutive stock options and grants based on the treasury stock method	1,585	860
Weighted average number of common shares and equivalents - diluted	100,157	98,571
Earnings per basic share attributable to UHS	$ 1.40	$ 1.23
Earnings per diluted share attributable to UHS	$ 1.38	$ 1.21

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Earnings Per Share Data ("EPS") and Stock Based Compensation - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Anti-dilutive weighted average stock options excluded from computation of earnings per share	0	0
Unrecognized compensation cost related to unvested options and restricted stock	$ 72,500,000
Unrecognized compensation cost, remaining weighted average vesting period in years	3 years 1 month 6 days
Stock options granted during period (net of cancellations)		2,772,100
Weighted-average grant date fair value, per share		$ 17.12
Compensation cost recognized	7,152,000	7,111,000
Excess tax benefit from share based compensation	11,750,000	9,266,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized	6,800,000	6,700,000
Compensation cost recognized, after-tax	4,300,000	4,200,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized	409,000	405,000
Compensation cost recognized, after-tax	$ 256,000	$ 252,000

Dispositions and Acquisitions - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended			1 Months Ended		3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014 Palo Verde Behavioral Health Bed	Apr. 30, 2014 Arbor Group, L.L.C Subsequent Event Contract Bed	Apr. 30, 2014 Psychiatric Institute Subsequent Event Bed	Mar. 31, 2013 Previously Closed Facilities Facility
Significant Acquisitions and Disposals [Line Items]
Number of management contracts				3
Number of beds			48	66	124
Payment to acquired real properties			$ 3
Aggregate cash proceeds from divestiture of businesses	11	7
Pre-tax gain proceeds from divestiture of businesses	$ 10
Number of facilities						2

Dividends - Additional Information (Detail) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Dividends [Line Items]
Dividends declared and paid, per share	$ 0.05	$ 0.05
Dividends declared and paid	$ 4.9	$ 4.9

Income Taxes - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Income Taxes [Line Items]
Unrecognized tax benefits		$ 3
Impact of unrecognized tax benefits if recognized		2
Jurisdictions statutes of limitations expiration period	12 months
Period of expiration of the statute of limitations for certain jurisdictions	Within the next twelve months
Minimum
Income Taxes [Line Items]
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	3 years
Maximum
Income Taxes [Line Items]
Accrued interest and penalties	$ 1
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	4 years

Supplemental Condensed Consolidating Statements of Income (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	$ 2,128,350	$ 2,078,348
Less: Provision for doubtful accounts	208,184	246,716
Net revenues	1,920,166	1,831,632
Operating charges:
Salaries, wages and benefits	935,365	902,296
Other operating expenses	381,760	381,007
Supplies expense	215,798	204,642
EHR incentive income	(430)	(4,712)
Depreciation and amortization	93,359	79,812
Lease and rental expense	23,338	24,665
Operating expenses	1,649,190	1,587,710
Income from operations	270,976	243,922
Interest expense, net	35,193	39,938
Interest (income) expense, affiliate	0	0
Equity in net income of consolidated affiliates	0	0
Income before income taxes	235,783	203,984
Provision for income taxes	83,931	74,049
Net income	151,852	129,935
Less: Income attributable to noncontrolling interests	13,774	10,151
Net income attributable to UHS	138,078	119,784
Parent
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	0	0
Less: Provision for doubtful accounts	0	0
Net revenues	0	0
Operating charges:
Salaries, wages and benefits	0	0
Other operating expenses	0	0
Supplies expense	0	0
EHR incentive income	0	0
Depreciation and amortization	0	0
Lease and rental expense	0	0
Operating expenses	0	0
Income from operations	0	0
Interest expense, net	33,573	37,946
Interest (income) expense, affiliate	0	0
Equity in net income of consolidated affiliates	(158,801)	(143,206)
Income before income taxes	125,228	105,260
Provision for income taxes	(12,850)	(14,524)
Net income	138,078	119,784
Less: Income attributable to noncontrolling interests	0	0
Net income attributable to UHS	138,078	119,784
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	1,463,920	1,421,852
Less: Provision for doubtful accounts	135,986	149,768
Net revenues	1,327,934	1,272,084
Operating charges:
Salaries, wages and benefits	669,253	645,594
Other operating expenses	240,176	244,419
Supplies expense	131,475	128,710
EHR incentive income	(430)	(3,116)
Depreciation and amortization	67,714	55,779
Lease and rental expense	14,349	15,675
Operating expenses	1,122,537	1,087,061
Income from operations	205,397	185,023
Interest expense, net	824	854
Interest (income) expense, affiliate	22,112	24,391
Equity in net income of consolidated affiliates	(42,952)	(31,781)
Income before income taxes	225,413	191,559
Provision for income taxes	78,753	65,323
Net income	146,660	126,236
Less: Income attributable to noncontrolling interests	0	0
Net income attributable to UHS	146,660	126,236
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	671,587	663,206
Less: Provision for doubtful accounts	72,198	96,948
Net revenues	599,389	566,258
Operating charges:
Salaries, wages and benefits	266,112	256,702
Other operating expenses	148,525	143,203
Supplies expense	84,323	75,932
EHR incentive income	0	(1,596)
Depreciation and amortization	25,645	24,033
Lease and rental expense	9,205	9,085
Operating expenses	533,810	507,359
Income from operations	65,579	58,899
Interest expense, net	796	1,138
Interest (income) expense, affiliate	(22,112)	(24,391)
Equity in net income of consolidated affiliates	0	0
Income before income taxes	86,895	82,152
Provision for income taxes	18,028	23,250
Net income	68,867	58,902
Less: Income attributable to noncontrolling interests	13,774	10,151
Net income attributable to UHS	55,093	48,751
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	(7,157)	(6,710)
Less: Provision for doubtful accounts	0	0
Net revenues	(7,157)	(6,710)
Operating charges:
Salaries, wages and benefits	0	0
Other operating expenses	(6,941)	(6,615)
Supplies expense	0	0
EHR incentive income	0	0
Depreciation and amortization	0	0
Lease and rental expense	(216)	(95)
Operating expenses	(7,157)	(6,710)
Income from operations	0	0
Interest expense, net	0	0
Interest (income) expense, affiliate	0	0
Equity in net income of consolidated affiliates	201,753	174,987
Income before income taxes	(201,753)	(174,987)
Provision for income taxes	0	0
Net income	(201,753)	(174,987)
Less: Income attributable to noncontrolling interests	0	0
Net income attributable to UHS	$ (201,753)	$ (174,987)

Supplemental Condensed Consolidating Comprehensive Income (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Comprehensive Income (Loss) [Line Items]
Net income	$ 151,852	$ 129,935
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	3,745	4,535
Amortization of terminated hedge	(84)	(84)
Other comprehensive income (loss) before tax	3,661	4,451
Income tax (benefit) expense related to items of other comprehensive income	1,354	1,678
Total other comprehensive income, net of tax	2,307	2,773
Comprehensive income	154,159	132,708
Less: Comprehensive income attributable to noncontrolling interests	13,774	10,151
Comprehensive income attributable to UHS	140,385	122,557
Parent
Comprehensive Income (Loss) [Line Items]
Net income	138,078	119,784
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	3,745	4,535
Amortization of terminated hedge	(84)	(84)
Other comprehensive income (loss) before tax	3,661	4,451
Income tax (benefit) expense related to items of other comprehensive income	1,354	1,678
Total other comprehensive income, net of tax	2,307	2,773
Comprehensive income	140,385	122,557
Less: Comprehensive income attributable to noncontrolling interests	0	0
Comprehensive income attributable to UHS	140,385	122,557
Guarantors
Comprehensive Income (Loss) [Line Items]
Net income	146,660	126,236
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0
Amortization of terminated hedge	0	0
Other comprehensive income (loss) before tax	0	0
Income tax (benefit) expense related to items of other comprehensive income	0	0
Total other comprehensive income, net of tax	0	0
Comprehensive income	146,660	126,236
Less: Comprehensive income attributable to noncontrolling interests	0	0
Comprehensive income attributable to UHS	146,660	126,236
Non Guarantors
Comprehensive Income (Loss) [Line Items]
Net income	68,867	58,902
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0
Amortization of terminated hedge	0	0
Other comprehensive income (loss) before tax	0	0
Income tax (benefit) expense related to items of other comprehensive income	0	0
Total other comprehensive income, net of tax	0	0
Comprehensive income	68,867	58,902
Less: Comprehensive income attributable to noncontrolling interests	13,774	10,151
Comprehensive income attributable to UHS	55,093	48,751
Consolidating Adjustments
Comprehensive Income (Loss) [Line Items]
Net income	(201,753)	(174,987)
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0
Amortization of terminated hedge	0	0
Other comprehensive income (loss) before tax	0	0
Income tax (benefit) expense related to items of other comprehensive income	0	0
Total other comprehensive income, net of tax	0	0
Comprehensive income	(201,753)	(174,987)
Less: Comprehensive income attributable to noncontrolling interests	0	0
Comprehensive income attributable to UHS	$ (201,753)	$ (174,987)

Supplemental Condensed Consolidating Balance Sheet (Detail) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 16,261	$ 17,238	$ 17,395	$ 23,471
Accounts receivable, net	1,212,594	1,116,961
Supplies	102,276	101,781
Other current assets	97,685	76,446
Deferred income taxes	114,297	119,903
Total current assets	1,543,113	1,432,329
Investments in subsidiaries	0	0
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	5,789,393	5,691,902
Less: accumulated depreciation	(2,321,221)	(2,249,733)
Property, Plant and Equipment, Net	3,468,172	3,442,169
Other assets:
Goodwill	3,053,666	3,049,016
Deferred charges	53,521	57,881
Other	312,913	330,328
Total assets	8,431,385	8,311,723	8,316,508
Current liabilities:
Current maturities of long-term debt	103,641	99,312
Accounts payable and accrued liabilities	954,902	953,449
Federal and state taxes	51,905	7,127
Total current liabilities	1,110,448	1,059,888
Intercompany payable	0	0
Other noncurrent liabilities	282,173	284,589
Long-term debt	3,109,158	3,209,762
Intercompany note payable	0	0
Deferred income taxes	257,344	239,148
Redeemable noncontrolling interests	228,107	218,107
UHS common stockholders' equity	3,392,119	3,249,979
Noncontrolling interest	52,036	50,250
Total equity	3,444,155	3,300,229
Liabilities and Equity, Total	8,431,385	8,311,723
Parent
Current assets:
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Supplies	0	0
Other current assets	0	0
Deferred income taxes	71,108	76,719
Total current assets	71,108	76,719
Investments in subsidiaries	6,537,300	6,378,499
Intercompany receivable	205,674	226,592
Intercompany note receivable	0	0
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, Plant and Equipment, Net	0	0
Other assets:
Goodwill	0	0
Deferred charges	45,425	49,866
Other	7,923	8,411
Total assets	6,867,430	6,740,087
Current liabilities:
Current maturities of long-term debt	101,903	97,403
Accounts payable and accrued liabilities	38,901	28,099
Federal and state taxes	49,753	4,963
Total current liabilities	190,557	130,465
Intercompany payable	0	0
Other noncurrent liabilities	4,202	7,591
Long-term debt	3,079,123	3,168,819
Intercompany note payable	0	0
Deferred income taxes	201,429	183,233
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	3,392,119	3,249,979
Noncontrolling interest	0	0
Total equity	3,392,119	3,249,979
Liabilities and Equity, Total	6,867,430	6,740,087
Guarantors
Current assets:
Cash and cash equivalents	7,719	7,990	8,317	11,949
Accounts receivable, net	864,487	799,898
Supplies	63,952	63,562
Other current assets	85,134	63,786
Deferred income taxes	43,189	43,184
Total current assets	1,064,481	978,420
Investments in subsidiaries	1,519,863	1,476,911
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	4,171,728	4,093,914
Less: accumulated depreciation	(1,532,857)	(1,478,758)
Property, Plant and Equipment, Net	2,638,871	2,615,156
Other assets:
Goodwill	2,553,615	2,552,190
Deferred charges	5,683	5,577
Other	243,381	251,365
Total assets	8,025,894	7,879,619
Current liabilities:
Current maturities of long-term debt	916	916
Accounts payable and accrued liabilities	822,487	837,354
Federal and state taxes	2,152	2,164
Total current liabilities	825,555	840,434
Intercompany payable	649,425	758,003
Other noncurrent liabilities	200,091	199,104
Long-term debt	5,109	5,337
Intercompany note payable	1,104,881	982,568
Deferred income taxes	55,915	55,915
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	5,184,918	5,038,258
Noncontrolling interest	0	0
Total equity	5,184,918	5,038,258
Liabilities and Equity, Total	8,025,894	7,879,619
Non Guarantors
Current assets:
Cash and cash equivalents	8,542	9,248	9,078	11,522
Accounts receivable, net	348,107	317,063
Supplies	38,324	38,219
Other current assets	12,551	12,660
Deferred income taxes	0	0
Total current assets	407,524	377,190
Investments in subsidiaries	0	0
Intercompany receivable	443,751	531,411
Intercompany note receivable	1,104,881	982,568
Property and equipment	1,617,665	1,597,988
Less: accumulated depreciation	(788,364)	(770,975)
Property, Plant and Equipment, Net	829,301	827,013
Other assets:
Goodwill	500,051	496,826
Deferred charges	2,413	2,438
Other	61,609	70,552
Total assets	3,349,530	3,287,998
Current liabilities:
Current maturities of long-term debt	822	993
Accounts payable and accrued liabilities	93,514	87,996
Federal and state taxes	0	0
Total current liabilities	94,336	88,989
Intercompany payable	0	0
Other noncurrent liabilities	77,880	77,894
Long-term debt	24,926	35,606
Intercompany note payable	0	0
Deferred income taxes	0	0
Redeemable noncontrolling interests	228,107	218,107
UHS common stockholders' equity	2,872,245	2,817,152
Noncontrolling interest	52,036	50,250
Total equity	2,924,281	2,867,402
Liabilities and Equity, Total	3,349,530	3,287,998
Consolidating Adjustments
Current assets:
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Supplies	0	0
Other current assets	0	0
Deferred income taxes	0	0
Total current assets	0	0
Investments in subsidiaries	(8,057,163)	(7,855,410)
Intercompany receivable	(649,425)	(758,003)
Intercompany note receivable	(1,104,881)	(982,568)
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, Plant and Equipment, Net	0	0
Other assets:
Goodwill	0	0
Deferred charges	0	0
Other	0	0
Total assets	(9,811,469)	(9,595,981)
Current liabilities:
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	0	0
Federal and state taxes	0	0
Total current liabilities	0	0
Intercompany payable	(649,425)	(758,003)
Other noncurrent liabilities	0	0
Long-term debt	0	0
Intercompany note payable	(1,104,881)	(982,568)
Deferred income taxes	0	0
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	(8,057,163)	(7,855,410)
Noncontrolling interest	0	0
Total equity	(8,057,163)	(7,855,410)
Liabilities and Equity, Total	$ (9,811,469)	$ (9,595,981)

Supplemental Condensed Consolidating Statements of Cash flows (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ 194,639	$ 178,497
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(92,387)	(95,919)
Proceeds received from sale of assets and businesses	11,450	6,657
Acquisition of property and businesses	(3,301)	0
Costs incurred for purchase and implementation of electronic health records application	(6,504)	(16,412)
Net cash provided by (used in) investing activities	(90,742)	(105,674)
Cash Flows from Financing Activities:
Reduction of long-term debt	(109,054)	(69,926)
Additional borrowings	11,900	9,500
Repurchase of common shares	(13,993)	(14,027)
Dividends paid	(4,933)	(4,870)
Issuance of common stock	1,445	1,232
Excess income tax benefits related to stock-based compensation	11,750	9,266
Profit distributions to noncontrolling interests	(1,989)	(10,074)
Changes in intercompany balances with affiliates, net	0	0
Net cash (used in) provided by financing activities	(104,874)	(78,899)
Decrease in cash and cash equivalents	(977)	(6,076)
Cash and cash equivalents, beginning of period	17,238	23,471
Cash and cash equivalents, end of period	16,261	17,395
Parent
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	70,888	64,747
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0
Proceeds received from sale of assets and businesses	0	0
Acquisition of property and businesses	0	0
Costs incurred for purchase and implementation of electronic health records application	0	0
Net cash provided by (used in) investing activities	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	(97,975)	(63,612)
Additional borrowings	11,900	9,500
Repurchase of common shares	(13,993)	(14,027)
Dividends paid	(4,933)	(4,870)
Issuance of common stock	1,445	1,232
Excess income tax benefits related to stock-based compensation	11,750	9,266
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	20,918	(2,236)
Net cash (used in) provided by financing activities	(70,888)	(64,747)
Decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	51,661	35,367
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(70,385)	(54,822)
Proceeds received from sale of assets and businesses	11,450	4,178
Acquisition of property and businesses	0	0
Costs incurred for purchase and implementation of electronic health records application	(6,504)	(16,412)
Net cash provided by (used in) investing activities	(65,439)	(67,056)
Cash Flows from Financing Activities:
Reduction of long-term debt	(228)	(265)
Additional borrowings	0	0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Excess income tax benefits related to stock-based compensation	0	0
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	13,735	28,322
Net cash (used in) provided by financing activities	13,507	28,057
Decrease in cash and cash equivalents	(271)	(3,632)
Cash and cash equivalents, beginning of period	7,990	11,949
Cash and cash equivalents, end of period	7,719	8,317
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	72,090	78,383
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(22,002)	(41,097)
Proceeds received from sale of assets and businesses	0	2,479
Acquisition of property and businesses	(3,301)	0
Costs incurred for purchase and implementation of electronic health records application	0	0
Net cash provided by (used in) investing activities	(25,303)	(38,618)
Cash Flows from Financing Activities:
Reduction of long-term debt	(10,851)	(6,049)
Additional borrowings	0	0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Excess income tax benefits related to stock-based compensation	0	0
Profit distributions to noncontrolling interests	(1,989)	(10,074)
Changes in intercompany balances with affiliates, net	(34,653)	(26,086)
Net cash (used in) provided by financing activities	(47,493)	(42,209)
Decrease in cash and cash equivalents	(706)	(2,444)
Cash and cash equivalents, beginning of period	9,248	11,522
Cash and cash equivalents, end of period	8,542	9,078
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0
Proceeds received from sale of assets and businesses	0	0
Costs incurred for purchase and implementation of electronic health records application	0	0
Net cash provided by (used in) investing activities	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	0	0
Additional borrowings	0	0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Excess income tax benefits related to stock-based compensation	0	0
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	0	0
Net cash (used in) provided by financing activities	0	0
Decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	$ 0	$ 0

Dividends	3 Months Ended
Dividends	Mar. 31, 2014
Dividends	(9) Dividends We declared and paid dividends of $4.9 million, or $.05 per share, during each of the first quarters of 2014 and 2013.

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail) (Guarantors)	Mar. 31, 2014
Guarantors
Supplementary Information [Line Items]
Percentage of ownership interests	100.00%